Skip to main content
Boditech Med Inc. logo

Boditech Med Inc. — Investor Relations & Filings

Ticker · 206640 ISIN · KR7206640005 KO Manufacturing
Open in API
Filings indexed 243 across all filing types
Latest filing 2026-02-20 Notice of Dividend Amou…
Country KR South Korea
Listing KO 206640

About Boditech Med Inc.

https://www.boditech.co.kr/

Boditech Med Inc. is a company specializing in the development, manufacturing, and distribution of in-vitro diagnostic (IVD) solutions. The company focuses on key technologies in immunodiagnostics and molecular diagnostics to provide a range of diagnostic instruments and reagents. Its products are engineered to deliver reliable and accessible testing for various healthcare applications, from point-of-care to laboratory settings. The company's mission is to enhance the quality of life by providing advanced and dependable diagnostic tools to healthcare professionals worldwide.

Recent filings

Filing Released Lang Actions
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Boditech Med regarding a decision on cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the date of the upcoming shareholder meeting for approval. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2026-02-20 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Preliminary Earnings Release' (잠정실적) for Boditech Med, detailing quarterly financial performance (revenue, operating profit, net income) for Q4 2025. It explicitly states that these are preliminary figures provided for investor convenience before the final audit. This fits the definition of an Earnings Release (ER), which is the initial announcement of periodic financial results. Q4 2025
2026-02-20 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Bodyitech Med. It outlines the date, location, agenda items (including financial statement approval, dividend declaration, and director appointments), and voting procedures. This document is a standard proxy solicitation material sent to shareholders to inform them of the upcoming meeting and request their participation/votes, which fits the definition of a Proxy Solicitation & Information Statement.
2026-02-20 Korean
주식소각결정
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement regarding a 'Decision to Cancel Shares' (주식소각 결정) by the company Boditech Med. It details the number of shares to be cancelled, the method (cancellation of treasury shares), and the scheduled date. This falls under the category of capital changes or corporate actions related to share structure, which is best classified as 'Share Issue/Capital Change' (SHA) as it pertains to the modification of the company's issued share capital.
2026-02-20 Korean
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount Classification · 98% confidence The document is a regulatory filing from Boditech Med regarding the setting of a record date for shareholder registry closure for the purpose of cash/in-kind dividends. It is a formal announcement of a corporate action related to dividend eligibility, which falls under the category of dividend-related announcements.
2026-02-20 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities regarding the 'Decision to Dispose of Treasury Shares' (자기주식 처분 결정). Specifically, it details the disposal of treasury shares to employees due to the exercise of stock options. According to the provided filing definitions, a report regarding the company buying back or selling its own shares (share repurchase/issuance) is classified as 'Transaction in Own Shares' (POS).
2026-02-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.